Skip to content
Hair Pipeline
← Recruiting trials
NCT07898566Completed

Efficacy and Safety of CosmeRNA-ARI Anti Hair Loss Tonic in Adults With Androgenetic Alopecia

A 24-Week, Double-Blind, Placebo-Controlled, Randomized Human Application Study to Evaluate the Efficacy and Safety of CosmeRNA-ARI Anti Hair Loss Tonic in Adults With Androgenetic Alopecia

In the register

This trial is not attached to a programme in the register yet. Unattached trials are kept on purpose: they are where new programmes turn up first.

What the registry records

Status
Completed
Declared phase
Not applicable (NA in the registry)
Sponsor
BIONEER Corporation
Participants (registry)
90
Start
December 2024
Primary completion
January 2026
Study completion
January 2026
Last registry update
October 2026
Countries
South Korea

Conditions studied: Androgenetic Alopecia

Interventions: Low-Concentration CosmeRNA-ARI Anti Hair Loss Tonic, High-Concentration CosmeRNA-ARI Anti Hair Loss Tonic, Vehicle Control Tonic Without CosmeRNA-AR

Full record on ClinicalTrials.gov ↗

Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first. A registration proves a sponsor declared a study, not that it is progressing or will succeed. We're not doctors.